165 related articles for article (PubMed ID: 2864052)
21. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
McDevitt DG; Brown HC; Carruthers SG; Shanks RG
Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
[TBL] [Abstract][Full Text] [Related]
22. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
23. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
O'Callaghan WG; Laher MS; McGarry K; O'Brien E; O'Malley K
Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
[TBL] [Abstract][Full Text] [Related]
24. Effects of betaxolol, propranolol, and atenolol on isoproterenol-induced beta-adrenoceptor responses.
Riddell JG; Shanks RG
Clin Pharmacol Ther; 1985 Nov; 38(5):554-9. PubMed ID: 2865028
[TBL] [Abstract][Full Text] [Related]
25. Effect of beta-adrenoceptor agents on the blood flow in carotid arteries in normal volunteers.
Fitzgerald DE; Harry JD
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):73S-74S. PubMed ID: 2572260
[TBL] [Abstract][Full Text] [Related]
26. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
27. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Chambers J; Ong ML; Akhras F; Adam G; Jackson G
Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
[TBL] [Abstract][Full Text] [Related]
28. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
Bilski A; Wale J; Dawes PM
Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
[No Abstract] [Full Text] [Related]
29. Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man.
Raptis S; Rosenthal J; Welzel D; Moulopoulos S
Eur J Clin Pharmacol; 1981; 20(1):17-22. PubMed ID: 6118277
[TBL] [Abstract][Full Text] [Related]
30. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
31. Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.
Koch G; Fransson L; Karlegärd L; Kothari P
Eur J Clin Pharmacol; 1989; 36(4):343-5. PubMed ID: 2567670
[TBL] [Abstract][Full Text] [Related]
32. Hemodynamics, biochemical and reflexive changes produced by atenolol in hypertension.
Dreslinski GR; Messerli FH; Dunn FG; Suarez DH; Reisin E; Frohlich ED
Circulation; 1982 Jun; 65(7):1365-8. PubMed ID: 6122514
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
34. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
35. Acute renal effects of beta-blockers.
Zech P; Pozet N; Labeeuw M; Laville M; Hadj-Aissa A; Arkouche W; Poncet JF
Am J Nephrol; 1986; 6 Suppl 2():15-9. PubMed ID: 2879466
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
[TBL] [Abstract][Full Text] [Related]
37. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
[TBL] [Abstract][Full Text] [Related]
38. Intrinsic sympathomimetic activity and coronary blood flow.
Berdeaux A; Giudicelli JF
Br J Clin Pharmacol; 1982; 13(Suppl 2):175S-180S. PubMed ID: 6125167
[TBL] [Abstract][Full Text] [Related]
39. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
40. [A study on the renal action of beta 1- and beta 2-adrenoceptors in rats].
Yamazaki N; Monma Y
Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):271-7. PubMed ID: 2878861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
